Updated:
Medytox Venture Investment
Medytox Venture Investment is a private equity firm based in South Korea. It focuses on venture capital investments. The firm has a team of six employees.
Overview
Medytox Venture Investment is a private equity firm based in South Korea. It focuses on venture capital investments. The firm has a team of six employees.
General information
Firm type
Venture Capital
Year founded
2017
Location
Region
Asia
Country
South Korea
City
Seoul
Corporate office
Seoul, South Korea
Sector focus
Frequently asked questions
How does Medytox Venture Investment structure its deals?
The firm favors direct equity stakes with strategic collaboration rights attached. Rather than operating as a purely financial investor, Medytox Venture Investment seeks portfolio companies where the parent corporation can serve as a development partner, clinical-trial collaborator, or commercialization channel. Fund commitments to third-party venture funds are not a disclosed part of the strategy.
What is the known scale of Medytox Venture Investment's assets under management?
Medytox Venture Investment does not publicly disclose its assets under management or total deployment figures. The unit functions as a captive corporate venture arm rather than as an independently capitalized fund manager, meaning investment capacity is determined by Medytox Inc.'s balance-sheet allocation decisions rather than by external limited-partner commitments.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: